Image of Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack An Overview of Major Trials and Meta-Analyses

LITERATURE

Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack An Overview of Major Trials and Meta-Analyses


Stroke is a leading cause of mortality and disability worldwide. Initial manifestations of acute cerebral ischemia, such as ischemic stroke and transient ischemic attack (TIA), are often followed by recurrent vascular events, including recurrent stroke. To reduce this burden,
antiplatelet therapy is a key component of the management of noncardioembolic ischemic stroke and TIA.


Availability

REQJ4499-2Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Stroke. 2019;50:773-778
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous